S. Kaw

Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence.

O. Gefeller, H. Ehrenreich, W. Poser, 1997, Alcoholism, clinical and experimental research.

The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes.

J. Vane, M. Hecker, S. Kaw, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery

M. Hecker, S. Kaw, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes.

J. Vane, M. Hecker, W. Sessa, 1991, Biochemical and biophysical research communications.

Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty

E. Rüther, O. Gefeller, H. Ehrenreich, 1997, Psychoneuroendocrinology.

A novelty-related sustained elevation of vasopressin plasma levels in young men is not associated with an enhanced response of adrenocorticotropic hormone (ACTH) to human corticotropin releasing factor (hCRF)

O. Gefeller, H. Ehrenreich, L. Schilling, 1996, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Novel selective quinazoline inhibitors of endothelin converting enzyme-1.

S. B. Herman, A. Doherty, D. Hupe, 1998, Biochemical and biophysical research communications.

Determination of endothelin-converting enzyme activity by high-performance liquid chromatography-on-line radioactive flow monitoring.

M. Hecker, S. Kaw, D. T. Walsh, 1992, Journal of chromatography.

ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

M. Yanagisawa, C. Slaughter, N. Emoto, 1994, Cell.

Characterization of Serine Protease‐Derived Metabolites of Big Endothelin in the Cytosolic Fraction from Human Polymorphonuclear Leukocytes

J. Vane, M. Hecker, T. Warner, 1992, Journal of cardiovascular pharmacology.

Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases.

J. Vane, E. Anggard, M. Hecker, 1991, Journal of cardiovascular pharmacology.